NeuroPace (NPCE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec17

NeuroPace Submits FDA Approval Supplemental Application for RNS System

13:01

Dec12

Wells Fargo Analyst Maintains NeuroPace Buy Rating

11:52

Dec8

NeuroPace Announces Positive 18-Month Results for RNS System in AES Conference NAUTILUS Trial

13:01

Nov5

NeuroPace released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 27.35 M (forecast USD 24.63 M), actual EPS USD -0.1055 (forecast USD -0.1955)

00:00

NeuroPace released FY2025 9 Months earnings on November 4 After-Market (EST), actual revenue USD 73.4 M, actual EPS USD -0.578

00:00

Oct28

NeuroPace to Release FY2025 Q3 Earnings on November 4 After-Market (EST), Forecast Revenue USD 24.63 M, EPS USD -0.1955

00:34

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 27.35 M, Net Income -3.496 M, EPS -0.1055

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 23.52 M, Net Income -8.651 M, EPS -0.2632

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 22.52 M, Net Income -6.589 M, EPS -0.2093

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change